We are testing a new treatment called RLY-2608 for individuals with advanced breast cancer and other solid tumors. This study aims to understand how safe and effective this treatment may be.
Health conditions and diseases that the clinical trial is designed to study and treat.
An advanced solid tumor with a PIK3CA mutation is a type of cancer that has spread beyond its original site and has a specific genetic mutation that can affect treatment options. This condition is often associated with breast cancer but can occur in other solid tumors as well.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
